Free Newsletter

FierceVaccines is a weekly update on the vaccine industry, with a special focus on the innovations revolutionizing the development and production of vaccines. Join thousands of lab research professionals who get FierceVaccines via weekly email. Sign up today!

About | View Sample | Privacy

Hottest Products

Compare Top Solutions in:

Evaluate more than 400,000 products >>

Featured Jobs

Clinical Trials Site Director
Lovelace Respiratory Research Institute - Albuquerque, NM
Manager, Strategic Forecasting & Analytics Job
Celgene Corporation - Basking Ridge, NJ, US
Clinical Research Coordinator
Lovelace Respiratory Research Institute - Albuquerque, NM
Analyst, Procurement Operations Job
Celgene Corporation - Basking Ridge, NJ, US
Patient Support Specialist Job
Celgene Corporation - Berkeley Heights, NJ, US

More Jobs >>

Events

Partnerships in Clinical Trials 2012
March 4-7 — Orlando, FL
New Paradigms to Fund & Move Biotech
January 11-12, 2012 — San Francisco, CA
Just Released: New Trends in Preventive and Therapeutic Vaccine
Pharmacovigilance and Risk Management Strategies 2012
January 22-25, 2012 — Arlington, Virginia

More Events >>

Related Tags >> Aeras Global TB Vaccine Foundation breast cancer Mayo Clinic Tuberculosis Vaccine

TapImmune News

Most Popular TapImmune Story

TapImmune, Aeras team on TB vaccine

November 3, 2011 — 6:30am ET | By Maureen Martino

TapImmune has signed a deal with non-profit development group Aeras for preclinical work on a tuberculous vaccine. TapImmune's technology is designed to make vaccines more effective by boosting Read more...

TapImmune Press Releases

TapImmune Inc. and Aeras Start Research & Development Collaboration
TapImmune Inc. and Aeras Start Research & Development Collaboration
TapImmune to Sponsor Phase 1 Breast Cancer Vaccine Trial Following Recent FDA Approval of Investigational New Drug Application

Latest Headlines

TapImmune, Aeras team on TB vaccine
November 3, 2011
TapImmune, Mayo Clinic announce Ph1 breast cancer vaccine trial
August 17, 2011

Paid Research Reports

Trends in mHealth and Telemedicine
The Global Aesthetic Dermatology Market Outlook
Future Directions in Regenerative Medicine
Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline

More Research Reports >>

THE FIERCEMARKETS NETWORK